Esophageal Cancer
Showing NaN - NaN of 29
Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))
Available
- Pancreatic Cancer
- +20 more
- Ulixertinib (BVD-523)
-
Birmingham, Alabama
- +25 more
Nov 4, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)
Active, not recruiting
- Esophageal Cancer
- Gastric Cancer
- Afatinib and Paclitaxel
-
Los Angeles, California
- +8 more
Mar 18, 2022
Barrett Esophagus, Esophageal Cancer Trial in United States (WATS-3D tissue sampling prior to forceps biopsies, WATS-3D tissue
Recruiting
- Barrett Esophagus
- Esophageal Cancer
- WATS-3D tissue sampling prior to forceps biopsies
- WATS-3D tissue sampling following forceps biopsies
-
Los Angeles, California
- +3 more
Sep 14, 2021
Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and
Completed
- Cervical Cancer
- +16 more
- INCAGN02385
-
Los Angeles, California
- +3 more
Oct 28, 2020
Esophageal Cancer, Gastric Cancer Trial in United States (everolimus, laboratory biomarker analysis)
Completed
- Esophageal Cancer
- Gastric Cancer
- everolimus
- laboratory biomarker analysis
-
Alhambra, California
- +17 more
Aug 3, 2020
Esophageal Cancer, Gastric Cancer Trial in United States (irinotecan HCl)
Completed
- Esophageal Cancer
- Gastric Cancer
- irinotecan hydrochloride
-
Bakersfield, California
- +24 more
Jul 30, 2020
Esophageal Cancer, Gastric Cancer Trial in Los Angeles, Chicago, Portland (irinotecan HCl, paclitaxel)
Completed
- Esophageal Cancer
- Gastric Cancer
- irinotecan hydrochloride
- paclitaxel
-
Los Angeles, California
- +3 more
Jul 30, 2020
Esophageal Cancer, Gastric Cancer Trial in Los Angeles (G17DT Immunogen, cisplatin, fluorouracil)
Completed
- Esophageal Cancer
- Gastric Cancer
- G17DT Immunogen
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United States (FOLFOX regimen,
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FOLFOX regimen
- +5 more
-
Mobile, Alabama
- +507 more
Oct 25, 2019
Gastric Cancer, Esophageal Cancer Trial in Los Angeles (oxaliplatin, capecitabine)
Unknown status
- Gastric Cancer
- Esophageal Cancer
- oxaliplatin, capecitabine
-
Los Angeles, CaliforniaU.S.C./Norris Comprehensive Cancer Center
May 14, 2019
Gastric Cancer, Gastric Adenocarcinoma, Esophageal Cancer Trial in Los Angeles, New York (Irinotecan, Cisplatin, Surgery)
Esophageal Cancer Trial in United States (procedure, radiation, drug)
Completed
- Esophageal Cancer
- conventional surgery
- +5 more
-
Birmingham, Alabama
- +34 more
Jan 20, 2017
Stomach Cancer, Esophageal Cancer Trial in United States (Ramucirumab, Placebo, Oxaliplatin)
Completed
- Stomach Cancer
- Esophageal Cancer
- Ramucirumab
- +4 more
-
Anchorage, Alaska
- +57 more
Oct 3, 2014
Esophageal Cancer Trial in Los Angeles (irinotecan, cisplatin, celecoxib)
Terminated
- Esophageal Cancer
- irinotecan, cisplatin, celecoxib
-
Los Angeles, CaliforniaU.S.C. / Norris Comprehensive Cancer Center
May 20, 2014
Esophageal Cancer, Gastric Cancer Trial in Canada, United States (erlotinib HCl)
Completed
- Esophageal Cancer
- Gastric Cancer
- erlotinib hydrochloride
-
Mobile, Alabama
- +106 more
Jun 21, 2013